What constitutes statin intolerance?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

What constitutes statin intolerance?

Statin intolerance means a patient cannot continue statin therapy at standard doses because of adverse effects that are attributed to the statin. The most common of these are muscle-related symptoms such as myalgias or weakness, which may occur with or without elevated CK, and elevations in liver enzymes. This definition focuses on the inability to tolerate the medication due to harmful effects, not on a lack of response to lowering LDL-C or on a general allergy to all medicines. It's helpful to recognize that this is about balancing benefit and harm with statin use. When someone truly intolerant, clinicians often try strategies to regain tolerance, such as lowering the dose, switching to a different statin with a different side-effect profile, using alternate-day dosing for certain statins, or adding non-statin therapies (like ezetimibe or PCSK9 inhibitors) to achieve LDL-C goals without the adverse effects that halted statin therapy.

Statin intolerance means a patient cannot continue statin therapy at standard doses because of adverse effects that are attributed to the statin. The most common of these are muscle-related symptoms such as myalgias or weakness, which may occur with or without elevated CK, and elevations in liver enzymes. This definition focuses on the inability to tolerate the medication due to harmful effects, not on a lack of response to lowering LDL-C or on a general allergy to all medicines.

It's helpful to recognize that this is about balancing benefit and harm with statin use. When someone truly intolerant, clinicians often try strategies to regain tolerance, such as lowering the dose, switching to a different statin with a different side-effect profile, using alternate-day dosing for certain statins, or adding non-statin therapies (like ezetimibe or PCSK9 inhibitors) to achieve LDL-C goals without the adverse effects that halted statin therapy.

More practice questions